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Evolutionary Change and The American Journal of
Pathology
Evolutionary theory has formed the underpinnings of
modern biology and since the last century has allowed us
to explore first prokaryotic1 and subsequently, eukaryotic
cellular pathophysiology.2 As recently as June of this
year, an international group of investigators used “molec-
ular clocks” to measure rates of mutation among bilat-
erian fossils back to approximately 600 million years
ago.3 In vitro selective pressure techniques which
evolved out of these early studies have allowed us to
begin applying gene therapy strategies to metabolic,
genetic, and neoplastic diseases.4–6
In common parlance, evolutionary change has been
used as a synonym for dramatic revolutionary change,
but truer to its original meaning the term represents a
slow but inevitable alteration and progression, albeit not
always in a direction with “staying power.” In the world of
scientific publishing, this is an exciting time as we are
truly in the throes of evolutionary change, both physically
and philosophically. Just as the practice of science is no
longer defined simply by looking into a microscope and
making notes onto a tablet, scientific publishing is no
longer simply the exchange of hand-written correspon-
dence between colleagues. As the discipline of biology
itself is defined by “evolutionary theory,” so too has sci-
entific publishing evolved in its role as a reflection and
record of that science. Increasing development of online
resources has enabled a huge proliferation in the means
by which research is accessed worldwide. Similar tech-
nological advancements have allowed the Journal to de-
velop new strategies for optimizing the peer review and
publication process, from the 1998 launch of AJP’s online
journal site to the most recent adoption of online manu-
script submission and review. The so-called “open ac-
cess debate” throws open yet another channel of possi-
bility for the world of scientific publishing. The AJP has
met this challenge by signing on to the DC Principles and
affirming its commitment to “innovative and independent
publishing practices” in “promoting the wide dissemina-
tion of information.”7 We have also joined with other non-
profit publishers to make the newest science available to
developing countries through free online access to the
Journal. These developments simply represent the by-
products of our primary mission: to advance scientific
research through responsible assessment, reporting,
and dissemination.
AJP Yesterday
We cannot move forward without first looking back. Just
as physical evolution depends on the building blocks of
its forebears, so must we acknowledge the changes
(both incremental and radical) that have brought us to
this point. In the AJP’s “centennial” issue (October 2001),
the previous Editor-in-Chief, James Madara, catalogued
the number of changes in the history of the Journal, from
its nascience to its current maturity as the leader in ex-
perimental pathology reporting.8
It has been approximately one year since The American
Journal of Pathology put in place a new editorial team and
with it has come its own evolutionary change. When Dr.
Madara bid farewell in June of last year,9 he listed as the
highlights of his tenure “progression and uniformity of
quality” of manuscripts, the requisite need to “handle
papers with respect,” the publication of leading edge
manuscripts, and the appointments of international Asso-
ciate Editors outside of North America. These are con-
cepts we have embraced and sustained. In September of
last year, I addressed the readership.10 In that treatise, I
talked about the progression of experimental pathology
from descriptive studies to molecular pathogenesis over
the last century. I tried to be all-inclusive of the evolving
areas of disease pathogenesis while welcoming the new
Associate Editors and saying good-bye to an outstanding
group of outgoing Associate Editors. At that time I solic-
ited suggestions and many of you responded. In May of
this year, I acknowledged with gratitude the long service
of retiring editorial board members, some of whom had
served for more than two decades.
AJP Today
With this issue a number of additional changes have
been put in place. Most obvious is the division of the table
of contents into topic categories for easy use by the
readership. The “Power-of-Ten,” a synopsis of the 10
most-read articles during the last month, has hopefully
become a commonly accessed feature and review arti-
cles and commentaries are more abundant. Other
changes, although equally important, are more subtle.
The Instructions to Authors has been extensively rewrit-
ten, the Associate Editors and Editorial Board have been
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expanded, a new Managing Editor and exuberant group
of Assistant Editors and Editorial Assistants have made
the now electronic submission and review of manuscripts
easier, resulting in reduced turn-around times from sub-
mission to publication.
Readers will also note a small but significant change in
the Journal’s mission statement on the masthead page.
This reflects a decision to publish only complete, full-
length research articles. Short communications, simple
reports of model systems, and purely technical advances
will no longer be accepted. Clinical articles that do not
explore underlying disease mechanisms will typically not
receive a high enough priority score to result in publica-
tion. This is not to say the Journal is not interested in
receiving manuscripts that use novel technologies, new
animal models, or bioinformatics. Rather it is the require-
ment to have these serve as a tool for exploration of
pathophysiologic mechanisms of disease rather than be-
ing the focus of the paper itself. To truly evolve the field of
experimental pathology, we must use these techniques
and models to answer the fundamental questions of sci-
ence itself.
AJP Tomorrow
Other plans are in the works for AJP and will be in
evidence shortly. Next year, we will be making website
pre-publication of accepted articles a reality. Additionally,
we are currently finalizing the process of hiring a Scientific
Editor to help with uniformity of abstracts and other key
operations. Finally, we are hoping to bring AJP’s vast ar-
chive of published science to today’s audience, by explor-
ing options for online archiving and access.
In all, much has happened over the last year and much
is on the horizon. It remains my goal to maintain AJP at
the forefront of experimental pathology investigation. With
large numbers of highest quality manuscript submissions
(now numbering more than 2000 per year) and an en-
gaged readership, I have little doubt this will be accom-
plished and we will continue to develop in a way that will
create a new evolutionary branch.
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